These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 23879951

  • 1. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Jiang H, Guan RJ, Wang HY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
    [Abstract] [Full Text] [Related]

  • 2. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL, Guan RJ, Xu QH, Wu ZY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
    [Abstract] [Full Text] [Related]

  • 3. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT, Schalij I, de Boer MA, Postmus PE, van Hinsbergh VW, van Nieuw Amerongen GP, Vonk Noordegraaf A, van der Laarse WJ.
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [Abstract] [Full Text] [Related]

  • 4. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H.
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
    [Abstract] [Full Text] [Related]

  • 5. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q, Chen Y, Chen X, Zhang J, Lu W, Wang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [Abstract] [Full Text] [Related]

  • 6. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
    Chen L, Xiao J, Li Y, Ma H.
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):1-7. PubMed ID: 21381494
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats.
    Elias-Al-Mamun M, Satoh K, Tanaka S, Shimizu T, Nergui S, Miyata S, Fukumoto Y, Shimokawa H.
    Circ J; 2014 Jan; 78(4):967-76. PubMed ID: 24553194
    [Abstract] [Full Text] [Related]

  • 8. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y, Jin H, Tian W, Wang H, Wang H, Zhao Y, Zhang Z, Meng F.
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [Abstract] [Full Text] [Related]

  • 9. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
    Liu Z, Duan YL, Ge SL, Zhang CX, Gong WH, Xu JJ.
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
    [Abstract] [Full Text] [Related]

  • 10. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL, Guan RJ, Li JJ.
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [Abstract] [Full Text] [Related]

  • 11. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
    Gupta N, Rashid J, Nozik-Grayck E, McMurtry IF, Stenmark KR, Ahsan F.
    Mol Pharm; 2017 Mar 06; 14(3):830-841. PubMed ID: 28165252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension].
    Li XW, Gao YX, Li S, Yang JR.
    Zhongguo Zhong Yao Za Zhi; 2015 Apr 06; 40(7):1355-61. PubMed ID: 26281561
    [Abstract] [Full Text] [Related]

  • 14. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
    Zhu R, Bi L, Kong H, Xie W, Hong Y, Wang H.
    Int J Clin Exp Pathol; 2015 Apr 06; 8(10):12169-76. PubMed ID: 26722401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
    Bei Y, Hua-Huy T, Duong-Quy S, Nguyen VH, Chen W, Nicco C, Batteux F, Dinh-Xuan AT.
    Pulm Pharmacol Ther; 2013 Dec 06; 26(6):635-43. PubMed ID: 23928001
    [Abstract] [Full Text] [Related]

  • 17. Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.
    Rashid J, Nahar K, Raut S, Keshavarz A, Ahsan F.
    Mol Pharm; 2018 May 07; 15(5):1755-1765. PubMed ID: 29528655
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maxingxiongting mixture attenuates hypoxia pulmonary arterial hypertension to improve right ventricular hypertrophy by inhibiting the rho-kinase signaling pathway.
    An X, Li S, Weng X, Wang X, Wu H, Zhang X, Gao J, Yang R, Peng B, Li S, Weng X, Wang X, Zhang X, Gao J.
    J Tradit Chin Med; 2020 Dec 07; 40(6):992-998. PubMed ID: 33258351
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.